|
1.
|
Tiseo M, Bartolotti M, Gelsomino F and
Ardizzoni A: First-line treatment in advanced non-small-cell lung
cancer: the emerging role of the histologic subtype. Expert Rev
Anticancer Ther. 9:425–435. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Stacker SA, Farnsworth RH, Karnezis T, et
al: Molecular pathways for lymphangiogenesis and their role in
human disease. Novartis Found Symp. 281:38–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Mandriota SJ, Jussila L, Jeltsch M, et al:
Vascular endothelial growth factor-C-mediated lymphangiogenesis
promotes tumour metastasis. EMBO J. 20:672–682. 2001. View Article : Google Scholar
|
|
5.
|
Stacker SA, Caesar C, Baldwin ME, et al:
Vascular endothelial growth factor-D promotes the metastatic spread
of cancer via the lymphatics. Nat Med. 7:186–191. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Schoppmann SF, Birner P, Stöckl J, et al:
Tumor-associated macrophages express lymphatic endothelial growth
factors and are related to peritumoral lymphangiogenesis. Am J
Pathol. 161:947–956. 2002. View Article : Google Scholar
|
|
7.
|
Schoppmann SF, Fenzl A, Nagy K, et al:
VEGF-C expressing tumor-associated macrophages in lymph node
positive breast cancer: impact on lymphangiogenesis and survival.
Surgery. 139:839–846. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Zhang B, Wang J, Gao J, et al:
Alternatively activated RAW264.7 macrophages enhance tumor
lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem.
107:134–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Renyi-Vamos F, Tovari J, Fillinger J, et
al: Lymphangiogenesis correlates with lymph node metastasis,
prognosis, and angiogenic phenotype in human non-small cell lung
cancer. Clin Cancer Res. 11:7344–7353. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Takanami I: Lymphatic microvessel density
using D2-40 is associated with nodal metastasis in non-small cell
lung cancer. Oncol Rep. 15:437–442. 2006.PubMed/NCBI
|
|
11.
|
Kadota K, Huang CL, Liu D, et al: The
clinical significance of lymphangiogenesis and angiogenesis in
non-small cell lung cancer patients. Eur J Cancer.
44:105710–105767. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Iwakiri S, Nagai S, Katakura H, et al:
D2-40-positive lymphatic vessel density is a poor prognostic factor
in squamous cell carcinoma of the lung. Ann Surg Oncol.
16:1678–1685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Faoro L, Hutto JY, Salgia R, et al:
Lymphatic vessel density is not associated with lymph node
metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med.
132:1882–1888. 2008.PubMed/NCBI
|
|
14.
|
Travis WD, Brambilla E, Noguchi M, et al:
International Association for the Study of Lung Cancer/American
Thoracic Society/European Respiratory Society International
Multidisciplinary Classification of lung adenocarcinoma. J Thorac
Oncol. 6:244–285. 2011. View Article : Google Scholar
|
|
15.
|
Kahn HJ and Marks A: A new monoclonal
antibody, D2-40, for detection of lymphatic invasion in primary
tumors. Lab Invest. 82:1255–1257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Kato S, Shimoda H, Ji RC and Miura M:
Lymphangiogenesis and expression of specific molecules as lymphatic
endothelial cell markers. Anat Sci Int. 81:71–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Braun M, Wardelmann E, Debald M, et al:
Detection of lymphovascular invasion in vulvar cancer by D2-40
(podoplanin) as a predictor for inguinal lymph node metastases.
Onkologie. 32:732–738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kitano H, Kageyama S, Hewitt SM, et al:
Podoplanin expression in cancerous stroma induces lymphangiogenesis
and predicts lymphatic spread and patient survival. Arch Pathol Lab
Med. 134:1520–1527. 2010.PubMed/NCBI
|
|
19.
|
Min KH, Park SJ, Lee KS, et al: Clinical
usefulness of D2-40 in non-small cell lung cancer. Lung. 189:57–63.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Raica M, Cimpean AM, Ceausu R and Ribatti
D: Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in
different molecular types of breast cancer. Anticancer Res.
31:1757–1764. 2011.PubMed/NCBI
|
|
21.
|
Kim HS, Sung W, Lee S, Chang SG and Park
YK: Lymphatic vessel densities of lymph node-negative prostate
adenocarcinoma in Korea. Pathol Res Pract. 205:249–254. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Saad RS, Kordunsky L, Liu YL, Denning KL,
Kandil HA and Silverman JF: Lymphatic microvessel density as
prognostic marker in colorectal cancer. Mod Pathol. 19:1317–1323.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Valencak J, Heere-Ress E, Kopp T,
Schoppmann SF, Kittler H and Pehamberger H: Selective
immunohistochemical staining shows significant prognostic influence
of lymphatic and blood vessels in patients with malignant melanoma.
Eur J Cancer. 40:358–364. 2004. View Article : Google Scholar
|
|
24.
|
Ali MA: Lymphatic microvessel density and
the expression of lymphangiogenic factors in oral squamous cell
carcinoma. Med Princ Pract. 17:486–492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Dadras SS, Paul T, Bertoncini J, et al:
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous
melanoma metastasis and survival. Am J Pathol. 162:1951–1960. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Maula SM, Luukkaa M, Grénman R, Jackson D,
Jalkanen S and Ristamäki R: Intratumoral lymphatics are essential
for the metastatic spread and prognosis in squamous cell carcinomas
of the head and neck region. Cancer Res. 63:1920–1926. 2003.
|
|
27.
|
Horiguchi A, Ito K, Sumitomo M, Kimura F,
Asano T and Hayakawa M: Intratumoral lymphatics and lymphatic
invasion are associated with tumor aggressiveness and poor
prognosis in renal cell carcinoma. Urology. 71:928–932. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Padera TP, Stoll BR, Tooredman JB, Capen
D, Di Tomaso E and Jain RK: Pathology: cancer cells compress
intratumour vessels. Nature. 427:6952004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Padera TP, Kadambi A, Di Tomaso E, et al:
Lymphatic metastasis in the absence of functional intratumor
lymphatics. Science. 296:1883–1886. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ji RC: Lymphatic endothelial cells, tumor
lymphangiogenesis and metastasis: new insights into intratumoral
and peritumoral lymphatics. Cancer Metastasis Rev. 25:677–694.
2006.PubMed/NCBI
|
|
31.
|
Wang XL, Fang JP, Tang RY and Chen XM:
Different significance between intratumoral and peritumoral
lymphatic vessel density in gastric cancer: a retrospective study
of 123 cases. BMC Cancer. 10:2992010. View Article : Google Scholar
|
|
32.
|
Gao Y, Liu Z, Gao F and Meng XY: High
density of peritumoral lymphatic vessels is a potential prognostic
marker of endometrial carcinoma: a clinical immunohistochemical
method study. BMC Cancer. 10:1312010. View Article : Google Scholar
|
|
33.
|
Adachi Y, Nakamura H, Kitamura Y, et al:
Lymphatic vessel density in pulmonary adenocarcinoma
immunohistochemically evaluated with anti-podoplanin or anti-D2-40
antibody is correlated with lymphatic invasion or lymph node
metastases. Pathol Int. 57:171–177. 2007. View Article : Google Scholar
|
